[Form 4] BROADRIDGE FINANCIAL SOLUTIONS, INC. Insider Trading Activity

Rhea-AI Filing Summary

Broadridge Financial Solutions (BR) filed a Form 4 for a company director reporting new equity awards granted on 11/13/2025. The director received 459 shares of common stock in the form of Deferred Stock Units at a price of $0.0000, increasing the director’s directly held common stock to 16,516 shares. The Deferred Stock Units vest in full upon grant and will be settled in Broadridge common stock when the director separates from service.

The filing also discloses a new stock option grant for 1,758 shares with an exercise price of $225.61 per share. These options vest immediately upon grant and are exercisable until their expiration on 11/13/2035. Both the common stock and the options are reported as directly owned by the director.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

keller brett

(Last) (First) (Middle)

5 DAKOTA DRIVE

(Street)

LAKE SUCCESS NY 11042

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BROADRIDGE FINANCIAL SOLUTIONS, INC. [ BR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		A		459	A	$0.0000(1)	16,516	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$225.61	11/13/2025		A		1,758		11/13/2025(2)	11/13/2035	Common Stock	1,758	$0.0000	1,758	D

Explanation of Responses:

1. The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

2. Stock options vest immediately upon grant.

	Maria Allen, Power of Attorney	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Broadridge (BR) disclose in this Form 4 filing?

Broadridge reported that a director received new equity awards on 11/13/2025, including 459 Deferred Stock Units (representing an equal number of common shares) and a stock option grant for 1,758 shares of Broadridge common stock.

How many Broadridge (BR) shares does the director now beneficially own?

After the reported transaction, the director beneficially owns 16,516 shares of Broadridge common stock directly, as shown in Table I of the filing.

What are the key terms of the 1,758 Broadridge stock options reported?

The director was granted stock options for 1,758 shares of Broadridge common stock with an exercise price of $225.61 per share. The options vest immediately upon grant and are exercisable until their expiration on 11/13/2035.

What are the terms of the 459 Deferred Stock Units granted by Broadridge (BR)?

The 459 Deferred Stock Units were granted under Broadridge’s 2018 Omnibus Award Plan and represent the right to receive an equal number of Broadridge common shares. They vest in full upon grant and will be settled in shares of common stock when the director separates from service with Broadridge.

Is this Form 4 transaction an open-market purchase of Broadridge (BR) shares?

No. The Form 4 describes equity awards granted to a director, including Deferred Stock Units and stock options, rather than an open-market purchase or sale of Broadridge shares.

What is the director’s relationship to Broadridge (BR) as shown in the Form 4?

The filing identifies the reporting person’s relationship to Broadridge as a Director, with the relevant box checked in the relationship section.